Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 8Unknown 4Terminated 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 22Squamous Cell Carcinoma of Head and Neck 16Colonic Neoplasms 11Rectal Neoplasms 8Head and Neck Neoplasms 7Neoplasm Metastasis 5Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Pancreatic Neoplasms 3Ovarian Neoplasms 2Esophageal Neoplasms 2Endometrial Neoplasms 2Chordoma 2Breast Neoplasms 2Unresectable Colorectal Cancer 1Tongue Neoplasms 1Thymoma 1Solid Tumor, Adult 1Solid Cancer 1Skin Neoplasms 1Rectal Diseases 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Oropharyngeal Neoplasms 1Noonan Syndrome 1Nasopharyngeal Carcinoma 1Mouth Neoplasms 1Metastatic Colorectal Adenocarcinoma 1Lymphoid Interstitial Pneumonia 1Lung Neoplasms 1Laryngeal Neoplasms 1

Interventions

Paclitaxel 8Radiotherapy 7Cisplatin 6pembrolizumab 4Fluorouracil 4Surgical Procedures, Operative 3Radiation 3Oxaliplatin 3Levoleucovorin 3Leucovorin 3Esophagectomy 3Drug Therapy 3Carboplatin 3lenvatinib 2durvalumab 2Taxes 2TP protocol 2Radiotherapy, Intensity-Modulated 2Nivolumab 2Neoadjuvant Therapy 2Irinotecan 2Capecitabine 2trifluridine tipiracil drug combination 1tislelizumab 1palbociclib 1osimertinib 1obinutuzumab 1nedaplatin 1naptumomab estafenatox 1futibatinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Esophageal Squamous Cell Carcinoma × Cetuximab × Clear all
NCT04229459 2026-01-14

Trial of Nivolumab and Cetuximab After Chemoradiation in Esophageal Squamous Cell Carcinoma Patients.

Rabin Medical Center

Phase 2 Active not recruiting
12 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡